SMN1 and myocardial infarction: Further, our research found that knockdown of METTL3 in vivo and in vitro can reduce the expression of ɑ‐SMA, inhibit the proliferation of CFs, reduce the area of cardiac fibrosis post‐MI and improve cardiac function.